Company / Total Assets
NovoCure Ltd Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$804.3M
FY2025
5-year range
$804.3M / $1.2B
FY2021-FY2025
Trend
-35.2%
vs FY2024
Sector context
#126 of 166
Health Care
What the data says
NovoCure Ltd's total assets of $804M is lower than 76% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $265M in FY2017 to $1.2B in FY2024.
Based on SEC 10-K filings.
$804M in FY2025 with a 5-year CAGR of -5.2%.
Declined from $1.1B to $804M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -12.3%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 166This company $804.3M Sector average $14.9B
▼
-94.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.2%, indicating a declining trend.
- In FY2025, total assets decreased 35.2% year-over-year.
- Ranks #126 out of 166 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $804.3M | -35.2% |
| FY2024 | $1.2B | +8.3% |
| FY2023 | $1.1B | -3.8% |
| FY2022 | $1.2B | +4.6% |
| FY2021 | $1.1B | +8.3% |
| FY2020 | $1.1B | +119.4% |
| FY2019 | $479.4M | +41.1% |
| FY2018 | $339.8M | +28.1% |
| FY2017 | $265.3M | -5.9% |
| FY2016 | $282.1M | -8.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026